A network meta-analysis of nonsmall-cell lung cancer patients with an activating EGFR mutation: Should osimertinib be the first-line treatment?

por Lin, Jia-Zhou, Ma, Song-Kun, Wu, Sheng-Xi, Yu, Shu-Han, Li, Xu-Yuan
Publicado 2018

CDK4/6 inhibition versus mTOR blockade as second-line strategy in postmenopausal patients with hormone receptor-positive advanced breast cancer: A network meta-analysis

por Huang, Hong-Wei, Huang, Li-Sheng, Xu, Qi-Ni, Wang, Hong-Biao, Li, Xu-Yuan, Lin, Jia-Zhou
Publicado 2019

Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response

por Weng, Zeng-Jie, Wu, Sheng-Xi, Luo, He-San, Du, Ze-Sen, Li, Xu-Yuan, Lin, Jia-Zhou
Publicado 2021